Velcade in MALT Lymphoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

Not specified

Conditions
MALT Lymphoma
Interventions
DRUG

Bortezomib (Velcade)

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00373906 - Velcade in MALT Lymphoma Patients | Biotech Hunter | Biotech Hunter